Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire.
Philippe-Richard J DomeyerSmaragda Ch GiannakidouPanagiota KyriakouVasiliki KatsariAntonios P AntoniadisIoannis K LagosNikolaos FragakisAgoritsa VarakliotiVassilios P VassilikosPublished in: BioMed research international (2018)
The Greek version of the U22 questionnaire is a valid tool to assess SVT-related symptoms. RF ablation appears to exert more pronounced beneficial outcomes on HRQoL of patients with SVTs compared to medical treatment. Prompt referral of patients with SVTs to specialist centers may favorably affect their quality of life and should be encouraged.